Outcome
    Moderate Evidence

    Probiotics for Cold Prevention

    Cochrane review: probiotics reduced the number of participants experiencing acute URTIs and shortened episodes by ~1–2 days. Effect sizes are modest and strain-specific, but consistent across analyses.

    Overview

    Cochrane review: probiotics reduced the number of participants experiencing acute URTIs and shortened episodes by ~1–2 days. Effect sizes are modest and strain-specific, but consistent across analyses.

    Verdict

    Mixed evidence

    Probiotics modestly reduce upper respiratory infection incidence and duration in meta-analyses.

    How It Works

    Gut-immune axis modulation: enhanced IgA production, competitive pathogen exclusion, and innate immune priming.

    Dosing & Protocol

    Typical dose

    Recommended dose
    Multi-strain product with Lactobacillus and Bifidobacterium, 10+ billion CFU daily during cold season.
    Expected timeframe
    4+ weeks of use before season; across a season.

    Protocol

    form
    Multi-strain products or specific strains including Lactobacillus rhamnosus GG, Lactobacillus casei Shirota and Bifidobacterium animalis subsp. lactis BB-12 have been used in respiratory infection trials
    duration
    3-6 months of continuous use across the season - this is preventive, not a treatment for a cold you already have
    co factor
    Take with food. Evidence is mixed but leans positive. A Cochrane review found probiotics were better than placebo at reducing the number of people experiencing acute upper respiratory tract infections, reducing the mean duration of an episode by about a day, and reducing antibiotic use - but the authors rated the evidence quality as low, noted substantial heterogeneity between strains and populations, and many trials were industry-funded. Effects are modest. The mechanism is thought to involve modulation of gut-associated lymphoid tissue, enhanced secretory IgA, and effects on innate and adaptive immune signalling.
    titration
    Up to 20 billion CFU/day; dose is less important than continuous daily use
    starting dose
    10 billion CFU/day with food, taken daily and continuously

    Evidence

    Probiotics for preventing acute upper respiratory tract infections

    Score: 8/10
    2022
    systematic_review

    Probiotics may modestly reduce upper respiratory infection episodes, but certainty of evidence is low.

    View source

    Safety

    Caveats

    Strain and product quality matter — effects are not universal across formulations. Refrigerated, third-party tested products preferred.

    Less likely to help if

    People wanting to shorten a cold already started, and immunocompromised people, for whom probiotics carry risk.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.